The largest database of trusted experimental protocols

131 protocols using β catenin

1

Protein Expression Analysis Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
BCA kit was used to determine the protein concentration. Proteins were then electrophoresed on sodium dodecyl sulfate-polyacrylamide gels (10%) and transferred to a polyvinylidene fluoride membrane. Primary antibodies against HMGB3 (1:1000; Proteintech Group), CD63 (1:5000; Proteintech Group), tumor susceptibility 101 (TSG101; 1:2000; Proteintech Group), β-catenin (1:2000; Proteintech Group), c-Myc (1:2000; Proteintech Group), non-phospho (active) β-catenin (1:1000; Abcam), and β-actin (1:1000; Proteintech Group) were used to incubate the membranes overnight at 4°C. Then, the membranes were incubated with the appropriate secondary antibodies for 1 h. An ECL kit was used for protein detection.
+ Open protocol
+ Expand
2

Protein Expression Analysis in Nuclear and Cytoplasmic Fractions

Check if the same lab product or an alternative is used in the 5 most similar protocols
Total protein was extracted by RIPA (Solarbio, Beijing), and the concentration was measured by bicinchoninic acid (Solarbio). The nuclear and cytoplasmic fractions were isolated by a Nuclear Extraction Kit (Solarbio, Beijing, China) according to the manufacturer‘s instruction. 80 μg/well proteins were loaded onto 10% SDS-PAGE for each sample, and proteins were transferred onto equilibrated polyvinylidene difluoride membranes (Millipore Corporation, Billerica, MA, USA) by electroblotting. Membranes were blocked with TBST containing 5% milk and incubated overnight at 4°C with primary antibodies against HO-1 (Bioworld Tech, LP, USA), Wnt1 (Abcam, Cambridge, MA, USA), Wnt5a (Novus Biologicals, Littleton, USA), β-catenin, GSK-3β, phospho-GSK-3β (Ser9) (ProteinTech Group, Chicago, USA), and NFAT5 (Santa Cruz, CA, USA). After incubation with the secondary antibody (ProteinTech), proteins expression was corrected by the amount of β-actin (ProteinTech) in the same sample. Lamin A (ProteinTech) and tubulin (ProteinTech) were used as the marker for nuclear and cytosolic proteins, respectively. The bands were quantified by scanning densitometry using Quantity One 4.6.3 software (Bio Rad).
+ Open protocol
+ Expand
3

Immunofluorescence analysis of BAP31 and β-catenin

Check if the same lab product or an alternative is used in the 5 most similar protocols
The cells were fixed with 4% paraformaldehyde for 30 min and then kept stable in 0.2% Triton X-100 for 30 min to rupture cell membranes. Subsequently, the cells were blocked with 2% bovine serum albumin for 30 min. The cells were then incubated overnight at 4 °C with antibodies against BAP31 antibody (1:200, Abcam, Cambridge, UK) and β-catenin (1:200, Proteintech, Wuhan, China). After washing, the cells were further incubated with the appropriate fluorescence-conjugated secondary antibody (CST, Danvers, MA, USA) for 1 h at room temperature and stained with DAPI (Beyotime). They were then examined by fluorescence microscopy (Leica).
+ Open protocol
+ Expand
4

Protein Expression and Apoptosis Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Membrane‐associated RING‐CH‐1 (Bioss, bs‐9335, Beijing, China), Phospho‐AKT Ser473 (SAB, 11054, Randallstown, MD, USA), total AKT (SAB, 21054), GAPDH (Proteintech, 10494‐1‐AP, Wuhan, Hubei, China), PI3K p110 β (Proteintech, 20584‐1‐AP), β‐catenin (Proteintech, 51067‐2‐AP), Mcl‐1 (Proteintech, 16225‐1‐AP), Bcl‐2 (Proteintech, 12789‐1‐AP), Cleaved caspase‐3 (CST, 9661, Fall River, MA, USA), Cleaved caspase‐7 (CST, 8438), secondary antibodies (Peroxidase‐conjugated Goat anti‐Rabbit IgG; ZSGB‐BIO, ZB‐2301, Beijing, China), Caspase‐3/7 Inhibitor I (ApexBio,A1925, Houston, TX, USA) and Pirarubicin (Selleck, Houston, TX, USA) were obtained commercially.
+ Open protocol
+ Expand
5

Protein Expression Analysis by Western Blot

Check if the same lab product or an alternative is used in the 5 most similar protocols
Proteins were isolated with RIPA lysis buffer (Beyotime, Jiangsu, China) after 48h of transfection. Protein lysates were separated by 10% sodium dodecyl sulfate-polyacrylamide gels and then transferred to nitrocellulose membrane (Beyotime, Jiangsu, China). nitrocellulose membrane with proteins were immunoblotted overnight at 4°C with primary antibodies: anti-PCNA (Proteintech, USA), anti-Wnt7b (Proteintech, USA), β-catenin (Proteintech, USA), Gsk-3β (Proteintech, USA), cyclin D1 (Abcam, USA), C-myc (Wanlei, China). Subsequently, the membranes were incubated in secondary antibodies for 1h at room temperature. Dilutions of all antibodies used in this study were 1:1000. Odyssey Infrared scanning system (Li-Cor, Lincoln, NE, USA) was used to visualize protein bands.
+ Open protocol
+ Expand
6

Co-Immunoprecipitation and Western Blot Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
IgG, HA, and GSK3β were added into lysis buffer gained from cells and incubated overnight at 4℃ with shaking. Then we mixed mix protein A/G PLUS‐agarose (Beyotime) and cell lysates and incubated with shaking for 2 h. Lysis buffer was used to wash the agarose beads for 3 times. The final cell lysates were separated by Western blotting. Total proteins were obtained using RIPA buffer (Beyotime) and separated on 8%–12% SDS‐PAGE. According to previous study,27 the PVDF membranes were probed by antibodies. The antibodies were listed as follow: β‐catenin (66379–1‐Ig, Proteintech, 1:1,000), Phospho‐β‐catenin (#9561, Cell Signaling Technology, 1:1,000), GSK3β (67329–1‐Ig, Proteintech, 1:1,000), HA tag (#5017, Cell Signaling Technology, 1:1,000), Vimentin (ab92547, Abcam, 1:1,000), E‐cadherin (ab40772, Abcam, 1:1,000), and β‐actin (AA128, Beyotime, 1:1,000). The expression levels were developed under enhanced chemiluminescence (ECL, Millipore).
+ Open protocol
+ Expand
7

Protein Expression Analysis by Western Blot

Check if the same lab product or an alternative is used in the 5 most similar protocols
Protein samples from cells were extracted by RIPA buffer (Beyotime, China) and separated in 10% SDS-PAGE gels and then transferred to PVDF membranes (Millipore, USA). The membranes were incubated with primary antibodies (anti-p-AKT-phosphoT308, 1:1000, abcam, England; anti-AKT, 1:1000, abcam, England; anti-p-GSK3β-phosphoS9, 1:1000, abcam, England; anti-GSK3β, 1:1000, abcam, England; cyclinD1, 1:500, Proteintech, China; cyclinE1, 1:500, Proteintech, China; p21, 1:1000, Proteintech, China; β-catenin, 1:500, Proteintech, China; vimentin, 1:500, Proteintech, China; E-cadherin, 1:500, Proteintech, China; N-cadherin, 1:500, Proteintech, China; TAF15, 1:500, Proteintech, China; RAB14, 1:500, abcam, England) overnight and then incubated with the corresponding secondary antibody. Band intensity was measured using chemiluminescence (ECL) system kit according to the manufacturer’s instructions (Solarbio, Beijing, China). The optical densities (OD) value was analyzed with ImageJ software (NIH, Bethesda, MD, USA).
+ Open protocol
+ Expand
8

Immunohistochemical Analysis of Tissue Markers

Check if the same lab product or an alternative is used in the 5 most similar protocols
Briefly, tissue sections were rehydrated and immersed in 0.3% H2O2, then treated with citrate buffer (10 mM, pH 6.0). Next, sections were treated with primary antibodies as follows: α-SMA (cat.ab5694, 1:200 dilution, Abcam), Collagen I (cat.ab138492, 1:500 dilution, Abcam), CD4 (cat.ab133616, 1:500 dilution, Abcam), β-catenin (cat.51067-2-AP, 1:100 dilution, Proteintech), CD44 (cat. ab51037, 1:50 dilution, Abcam) overnight at 4 °C, followed by secondary antibodies and 20 min incubation with the avidin-biotin complex at room temperature. Sections were visualized with diaminobenzidine tetrahidrochloryde substrate and hematoxylin counterstain. Images were acquired with a Leica microscope (DM4000B) at × 200 or × 400 magnification.
+ Open protocol
+ Expand
9

Immunofluorescence Staining of Wnt Pathway

Check if the same lab product or an alternative is used in the 5 most similar protocols
FLS were fixed in 4% paraformaldehyde for 20 min, after which 0.5% Triton X-100 diluted in phosphate-buffered saline (PBS, Gibco, 8118311) was added to the wells and incubated for 20 min. Sections were rinsed three times with PBS, and 5% bovine serum albumin was added to these sections and blocked for 30 min. Diluted primary antibody: Wnt7b (Abcam, GR3241134-2 1 : 500); β-catenin (Proteintech, 00077341, 1 : 200); c-Myc (Proteintech, 00033258, 1 : 50); cyclin D1 (Abcam, GR197045-1, 1 : 50), p-GSK-3β(Ser9) (CST, #5588, 1 : 400); SFRP4 (Wuhan Aibotek Biotechnology Co., Ltd., 9100014210, 1 : 500) was added, and samples were placed in a humid box and incubated overnight at 4°C in the dark. Then, the corresponding second antibody was added and incubated at room temperature for 50 min. DAPI (Beijing Soleibo Technology Co., Ltd., 20181120) was used to stain the cell nucleus.
+ Open protocol
+ Expand
10

Western Blot Analysis of EMT Pathway

Check if the same lab product or an alternative is used in the 5 most similar protocols
Western blot was carried out according as described [41 (link), 42 (link)] with rabbit polyclonal PLOD2, E-cadherin and β-catenin antibodies (1:1000; Proteintech, USA), PI3K, p-PI3K (Tyr458), AKT, p-AKT (Ser473), GSK-3β, p-GSK-3β, N-Cadherin, Slug and Vimentin antibodies (1:1000; Cell Signaling Technology, Danvers, MA, USA), as well as Snail antibody (1:1000; Abcam, USA). Mouse monoclonal HIF-1α antibody (1:50; Novus Biologicals, USA) was used for normalization. An HRP-conjugated anti-rabbit or anti-mouse IgG antibody was used as the secondary antibody (1:2000; CoWin Bioscience, Beijing, China). Signals were detected using enhanced chemiluminescence reagents (Pierce, Rockford, IL, USA).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!